Lexeo Therapeutics, Inc. (LXEO) Form 10-Q Quarterly Reports
Lexeo Therapeutics, Inc. (LXEO) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LXEO
CIK: 1907108
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerHarry Cohen
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-13 | — | SCHEDULE 13G Filing | 0000019617-26-000349 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-29 | 8-K | 0001193125-26-407555 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 Filing | 0002083206-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 Filing | 0002109299-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 Filing | 0002024096-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 Filing | 0001995218-26-000017 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-16 | 8-K | 0001193125-26-397221 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-18 | 4 Filing | 0002083206-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-18 | 4 Filing | 0001995218-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-18 | 4 Filing | 0002024096-26-000013 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001959173-26-006154 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001959173-26-006153 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001959173-26-006152 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000947871-26-000801 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097207 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003428 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001011438-26-000515 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-345724 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001193125-26-345722 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000489 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | 4 Filing | 0002083206-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | 4 Filing | 0002024096-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | 4 Filing | 0002109299-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | 4 Filing | 0001995218-26-000013 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001959173-26-005036 | View SEC Doc Filr Page |